600812.SS · 华北制药
China A-shares · RS rating 95 · As of 2026-10-14
| Price | 5.97 CNY |
|---|---|
| 1-day change | +0.0% |
| RS rating (overall / 1M / 3M / 12M) | 95 / 98 / 95 / 72 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 55 / 35 / 55 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -4.0% |
| Distance from 52-week high | +9.9% |
| Market cap (USD) | $1.4B |